Comorbidities, comedications and polypharmacy among people living with HIV and associated challenges with HIV antiretroviral therapy: Findings from people living with HIV in four c...

by Chinyere Okoli, Laurent Finkielsztejn, Ama Appiah, Pascal Pugliese, Corinne V. Fructuoso, Patricia de los Rios
Published 2022-07-01

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France.

by Gilles Pialoux, Anne-Geneviève Marcelin, Nicolas Despiégel, Caroline Espinas, Hélène Cawston, Laurent Finkielsztejn, Audrey Laurisse, Céline Aubin
Published 2015-01-01

Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database

by Martin Prodel, Laurent Finkielsztejn, Laëtitia Roustand, Gaëlle Nachbaur, Lucie de Leotoing, Marie Genreau, Fabrice Bonnet, Jade Ghosn
Published 2021-11-01

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.

by Valérie Potard, Jacques Reynes, Tristan Ferry, Céline Aubin, Laurent Finkielsztejn, Yazdan Yazdanpanah, Dominique Costagliola, FHDH ANRS CO4
Published 2015-01-01

Quantifying people living with HIV who would benefit from an alternative to daily oral therapy: Perspectives from HIV physicians and people living with HIV

by Laura Clark, Chitra Karki, Josh Noone, Jenny Scherzer, Martina Bode, Paolo Rizzini, Fabio Vecchio, Laetitia Roustand, Gaelle Nachbaur, Laurent Finkielsztejn, Vasiliki Chounta, Nicolas Van de Velde
Published 2020-10-01